<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(2)</volume><submitter>Bossini-Castillo L</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>CD226 genetic variants have been associated with a number of autoimmune diseases and recently with systemic sclerosis (SSc). The aim of this study was to test the influence of CD226 loci in SSc susceptibility, clinical phenotypes and autoantibody status in a large multicenter European population.&lt;h4>Methods&lt;/h4>A total of seven European populations of Caucasian ancestry were included, comprising 2,131 patients with SSc and 3,966 healthy controls. Three CD226 single nucleotide polymorphisms (SNPs), rs763361, rs3479968 and rs727088, were genotyped using Taqman 5'allelic discrimination assays.&lt;h4>Results&lt;/h4>Pooled analyses showed no evidence of association of the three SNPs, neither with the global disease nor with the analyzed subphenotypes. However, haplotype block ana</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pagination>R85</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3446459</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.</pubmed_title><pmcid>PMC3446459</pmcid><pubmed_authors>Sanchez-Roman J</pubmed_authors><pubmed_authors>Kreuter A</pubmed_authors><pubmed_authors>Castillo MJ</pubmed_authors><pubmed_authors>Ortego-Centeno N</pubmed_authors><pubmed_authors>Gonzalez-Gay MA</pubmed_authors><pubmed_authors>de la Pena PG</pubmed_authors><pubmed_authors>Saez-Comet L</pubmed_authors><pubmed_authors>van Laar JM</pubmed_authors><pubmed_authors>Martin J</pubmed_authors><pubmed_authors>Fernandez-Nebro A</pubmed_authors><pubmed_authors>Tolosa C</pubmed_authors><pubmed_authors>Narvaez J</pubmed_authors><pubmed_authors>Lunardi C</pubmed_authors><pubmed_authors>Gomez-Gracia I</pubmed_authors><pubmed_authors>de Castro MF</pubmed_authors><pubmed_authors>Lopez-Longo FJ</pubmed_authors><pubmed_authors>Camps MT</pubmed_authors><pubmed_authors>Vonk MC</pubmed_authors><pubmed_authors>Witte T</pubmed_authors><pubmed_authors>Bossini-Castillo L</pubmed_authors><pubmed_authors>Rios-Fernandez R</pubmed_authors><pubmed_authors>Garcia-Hernandez FJ</pubmed_authors><pubmed_authors>Andreu JL</pubmed_authors><pubmed_authors>Gonzalez-Escribano MF</pubmed_authors><pubmed_authors>Martinez L</pubmed_authors><pubmed_authors>Denton CP</pubmed_authors><pubmed_authors>Navarrete N</pubmed_authors><pubmed_authors>Schuerwegh AJ</pubmed_authors><pubmed_authors>Vaqueiro I</pubmed_authors><pubmed_authors>Gallego M</pubmed_authors><pubmed_authors>Simeon CP</pubmed_authors><pubmed_authors>Beltran E</pubmed_authors><pubmed_authors>Radstake TR</pubmed_authors><pubmed_authors>Diaz F</pubmed_authors><pubmed_authors>Castellvi I</pubmed_authors><pubmed_authors>Hoffmann-Vold AM</pubmed_authors><pubmed_authors>Egurbide MV</pubmed_authors><pubmed_authors>Espinosa G</pubmed_authors><pubmed_authors>Diaz B</pubmed_authors><pubmed_authors>Roman-Ivorra JA</pubmed_authors><pubmed_authors>Beretta L</pubmed_authors><pubmed_authors>Portales RG</pubmed_authors><pubmed_authors>Carreira P</pubmed_authors><pubmed_authors>Aguirre MA</pubmed_authors><pubmed_authors>Fernandez-Gutierrez B</pubmed_authors><pubmed_authors>Rodriguez-Rodriguez L</pubmed_authors><pubmed_authors>Chee MM</pubmed_authors><pubmed_authors>del Rocio V</pubmed_authors><pubmed_authors>Broen JC</pubmed_authors><pubmed_authors>Koeleman BP</pubmed_authors><pubmed_authors>Trapiella L</pubmed_authors><pubmed_authors>Pros A</pubmed_authors><pubmed_authors>Hesselstrand R</pubmed_authors><pubmed_authors>Fonollosa V</pubmed_authors><pubmed_authors>Hernandez V</pubmed_authors><pubmed_authors>Callejas JL</pubmed_authors><pubmed_authors>Carmen Freire Md</pubmed_authors><pubmed_authors>Herrick A</pubmed_authors><pubmed_authors>Spanish Scleroderma Group</pubmed_authors><pubmed_authors>Fonseca C</pubmed_authors><pubmed_authors>Carballeira MR</pubmed_authors></additional><is_claimable>false</is_claimable><name>A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.</name><description>&lt;h4>Introduction&lt;/h4>CD226 genetic variants have been associated with a number of autoimmune diseases and recently with systemic sclerosis (SSc). The aim of this study was to test the influence of CD226 loci in SSc susceptibility, clinical phenotypes and autoantibody status in a large multicenter European population.&lt;h4>Methods&lt;/h4>A total of seven European populations of Caucasian ancestry were included, comprising 2,131 patients with SSc and 3,966 healthy controls. Three CD226 single nucleotide polymorphisms (SNPs), rs763361, rs3479968 and rs727088, were genotyped using Taqman 5'allelic discrimination assays.&lt;h4>Results&lt;/h4>Pooled analyses showed no evidence of association of the three SNPs, neither with the global disease nor with the analyzed subphenotypes. However, haplotype block ana</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Apr</publication><modification>2026-04-07T18:28:42.995Z</modification><creation>2019-03-27T00:58:08Z</creation></dates><accession>S-EPMC3446459</accession><cross_references><pubmed>22531499</pubmed><doi>10.1186/ar3809</doi></cross_references></HashMap>